BR112021023832A8 - Métodos e composições para geração de óxido nítrico e usos dos mesmos - Google Patents
Métodos e composições para geração de óxido nítrico e usos dos mesmosInfo
- Publication number
- BR112021023832A8 BR112021023832A8 BR112021023832A BR112021023832A BR112021023832A8 BR 112021023832 A8 BR112021023832 A8 BR 112021023832A8 BR 112021023832 A BR112021023832 A BR 112021023832A BR 112021023832 A BR112021023832 A BR 112021023832A BR 112021023832 A8 BR112021023832 A8 BR 112021023832A8
- Authority
- BR
- Brazil
- Prior art keywords
- nitric oxide
- compositions
- generation
- methods
- organic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B21/00—Nitrogen; Compounds thereof
- C01B21/20—Nitrogen oxides; Oxyacids of nitrogen; Salts thereof
- C01B21/24—Nitric oxide (NO)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
MÉTODOS E COMPOSIÇÕES PARA GERAÇÃO DE ÓXIDO NÍTRICO E USOS DOS MESMOS. A invenção fornece uma combinação, kit ou composição compreendendo: (i) um ou mais sais de nitrito; (ii) uma fonte de próton compreendendo um ou mais ácidos selecionados de ácidos carboxílicos orgânicos e ácidos orgânicos não carboxílicos redutores; e (iii) um ou mais polióis orgânicos. Na reação do um ou mais sais de nitrito com a fonte de próton na presença do um ou mais polióis orgânicos, a combinação, kit ou composição fornece produtos de reação que incluem óxido nítrico, opcionalmente outros óxidos de nitrogênio e/ou opcionalmente precursores dos mesmos e que são úteis, por exemplo, no tratamento de vários distúrbios.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1907969.8A GB201907969D0 (en) | 2019-06-04 | 2019-06-04 | Methods and compositions for generating nitric oxide and uses thereof |
GB201915280A GB201915280D0 (en) | 2019-10-22 | 2019-10-22 | Methods and compositions for generating nitric oxide and uses thereof |
GBGB2005980.4A GB202005980D0 (en) | 2020-04-23 | 2020-04-23 | Methods and compositions for generating nitric oxide and uses thereof |
PCT/GB2020/051328 WO2020245573A1 (en) | 2019-06-04 | 2020-06-02 | Methods and compositions for generating nitric oxide and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112021023832A2 BR112021023832A2 (pt) | 2022-01-04 |
BR112021023832A8 true BR112021023832A8 (pt) | 2023-02-28 |
Family
ID=71083655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112021023832A BR112021023832A8 (pt) | 2019-06-04 | 2020-06-02 | Métodos e composições para geração de óxido nítrico e usos dos mesmos |
Country Status (9)
Country | Link |
---|---|
US (1) | US20220370493A1 (pt) |
EP (1) | EP3980373A1 (pt) |
JP (1) | JP2023510661A (pt) |
CN (1) | CN114206325A (pt) |
AU (1) | AU2020286677A1 (pt) |
BR (1) | BR112021023832A8 (pt) |
CA (1) | CA3142101A1 (pt) |
GB (1) | GB2599576B (pt) |
WO (1) | WO2020245573A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10517817B2 (en) | 2013-05-09 | 2019-12-31 | Syk Technologies, Llc | Deep topical systemic nitric oxide therapy apparatus and method |
US20230172973A1 (en) * | 2020-04-23 | 2023-06-08 | Thirty Respiratory Limited | Methods and compositions for treating and combatting tuberculosis |
CN115884758A (zh) * | 2020-04-23 | 2023-03-31 | 三十呼吸有限公司 | 用于治疗SARS-CoV和SARS-CoV-2的一氧化氮或释放一氧化氮的组合物 |
JPWO2021256540A1 (pt) * | 2020-06-19 | 2021-12-23 |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3826255A (en) | 1972-06-22 | 1974-07-30 | Hudson Oxygen Therapy Sales Co | Intermittent positive pressure breathing manifold |
YU41046B (en) | 1974-08-22 | 1986-10-31 | Schering Ag | Medicine inholating device |
US4130639A (en) | 1977-09-28 | 1978-12-19 | Ethicon, Inc. | Absorbable pharmaceutical compositions based on isomorphic copolyoxalates |
US4268460A (en) | 1977-12-12 | 1981-05-19 | Warner-Lambert Company | Nebulizer |
US4253468A (en) | 1978-08-14 | 1981-03-03 | Steven Lehmbeck | Nebulizer attachment |
US4263907A (en) | 1979-05-14 | 1981-04-28 | Lindsey Joseph W | Respirator nebulizer |
US4510929A (en) | 1982-04-30 | 1985-04-16 | Bordoni Maurice E | Disposable radioactive aerosol inhalation apparatus |
US4649911A (en) | 1983-09-08 | 1987-03-17 | Baylor College Of Medicine | Small particle aerosol generator for treatment of respiratory disease including the lungs |
US4624251A (en) | 1984-09-13 | 1986-11-25 | Riker Laboratories, Inc. | Apparatus for administering a nebulized substance |
NZ241579A (en) | 1991-03-25 | 1994-04-27 | Becton Dickinson Co | Antimicrobial formulations for treating the skin |
US5164740A (en) | 1991-04-24 | 1992-11-17 | Yehuda Ivri | High frequency printing mechanism |
ATE155695T1 (de) | 1991-11-07 | 1997-08-15 | Ritzau Pari Werk Gmbh Paul | Vernebler insbesondere zur anwendung in geräten für die inhalationstherapie |
US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
US5709202A (en) | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
WO1995009605A1 (en) | 1993-10-06 | 1995-04-13 | Henkel Corporation | Improving phenolic disinfectant cleaning compositions with alkylpolyglucoside surfactants |
US6034133A (en) | 1993-11-05 | 2000-03-07 | The University Of Virginia Patents Foundation | Use of a virucidal hand lotion to prevent the spread of rhinovirus colds |
ATE264685T1 (de) | 1994-02-21 | 2004-05-15 | Univ Aberdeen | Angesäuertes nitrit zur verwendung als antimikrobielles mittel |
GB9804469D0 (en) | 1998-03-02 | 1998-04-29 | Univ Aberdeen | Antiviral composition |
US5681802A (en) | 1994-06-01 | 1997-10-28 | Lever Brothers Company, Division Of Conopco, Inc. | Mild antimicrobial liquid cleansing formulations comprising buffering compound or compounds as potentiator of antimicrobial effectiveness |
US5635462A (en) | 1994-07-08 | 1997-06-03 | Gojo Industries, Inc. | Antimicrobial cleansing compositions |
US5776430A (en) | 1994-11-01 | 1998-07-07 | Calgon Vestal, Inc. | Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol |
US5702754A (en) | 1995-02-22 | 1997-12-30 | Meadox Medicals, Inc. | Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings |
WO1996025918A1 (en) | 1995-02-24 | 1996-08-29 | Nanosystems L.L.C. | Aerosols containing nanoparticle dispersions |
ZA962455B (en) | 1995-03-31 | 1996-10-02 | B Eugene Guthery | Fast acting and persistent topical antiseptic |
US5758637A (en) | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US5586550A (en) | 1995-08-31 | 1996-12-24 | Fluid Propulsion Technologies, Inc. | Apparatus and methods for the delivery of therapeutic liquids to the respiratory system |
US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
US6083922A (en) | 1996-04-02 | 2000-07-04 | Pathogenesis, Corp. | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis |
JP2002514163A (ja) | 1996-07-10 | 2002-05-14 | ステリス インコーポレイテッド | 改良された有効性を有するトリクロサンスキンウォッシュ |
AU743174B2 (en) | 1997-10-08 | 2002-01-17 | Sepracor, Inc. | Dosage form for aerosol administration |
US5906202A (en) | 1996-11-21 | 1999-05-25 | Aradigm Corporation | Device and method for directing aerosolized mist to a specific area of the respiratory tract |
US6349719B2 (en) | 1997-02-24 | 2002-02-26 | Aradigm Corporation | Formulation and devices for monitoring the efficacy of the delivery of aerosols |
US6258368B1 (en) | 1997-06-04 | 2001-07-10 | The Procter & Gamble Company | Antimicrobial wipes |
US5855564A (en) | 1997-08-20 | 1999-01-05 | Aradigm Corporation | Aerosol extrusion mechanism |
EP1149602B1 (en) | 1997-11-19 | 2015-01-07 | Aptar France SAS | Spray device for an inhaler suitable for respiratory therapies |
US6192876B1 (en) | 1997-12-12 | 2001-02-27 | Astra Aktiebolag | Inhalation apparatus and method |
US6258371B1 (en) | 1998-04-03 | 2001-07-10 | Medtronic Inc | Method for making biocompatible medical article |
US6103275A (en) | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
AU5180999A (en) | 1998-07-31 | 2000-02-21 | First Water Limited | Bioadhesive compositions comprising hydrophobic polymers |
GB2343122B (en) | 1998-10-26 | 2003-01-08 | Medic Aid Ltd | Improvements in and relating to nebulisers |
US6070575A (en) | 1998-11-16 | 2000-06-06 | Aradigm Corporation | Aerosol-forming porous membrane with certain pore structure |
US6584971B1 (en) | 1999-01-04 | 2003-07-01 | Medic-Aid Limited | Drug delivery apparatus |
GB9905425D0 (en) | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
JP2000355667A (ja) | 1999-04-14 | 2000-12-26 | Seiko Epson Corp | カラーインクジェット記録用水系顔料インクセット、カラーインクジェット記録方法、及びカラーインクジェット記録物 |
US6338443B1 (en) | 1999-06-18 | 2002-01-15 | Mercury Enterprises, Inc. | High efficiency medical nebulizer |
US6107261A (en) | 1999-06-23 | 2000-08-22 | The Dial Corporation | Compositions containing a high percent saturation concentration of antibacterial agent |
CA2733850C (en) | 2000-04-11 | 2013-10-22 | Trudell Medical International | Aerosol delivery apparatus with positive expiratory pressure capacity |
GB0021317D0 (en) | 2000-08-30 | 2000-10-18 | Queen Mary & Westfield College | Transdermal pharmaceutical delivery composition |
GB0022084D0 (en) * | 2000-09-08 | 2000-10-25 | Univ Aberdeen | Treatment of multiply antibiotic-resistant organisms |
US6601581B1 (en) | 2000-11-01 | 2003-08-05 | Advanced Medical Applications, Inc. | Method and device for ultrasound drug delivery |
GB0119011D0 (en) | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
US7135189B2 (en) | 2001-08-23 | 2006-11-14 | Boston Scientific Scimed, Inc. | Compositions and techniques for localized therapy |
GB0125222D0 (en) | 2001-10-19 | 2001-12-12 | Barts & London Nhs Trust | Composition for the treatment of microbial infections |
US7066356B2 (en) | 2002-08-15 | 2006-06-27 | Ecolab Inc. | Foam soap dispenser for push operation |
EP1718603A4 (en) | 2004-02-09 | 2009-09-23 | Noxilizer Inc | MOLECULES RELEASING NITROGEN MONOXIDE |
US7838532B2 (en) | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
WO2007007115A2 (en) | 2005-07-14 | 2007-01-18 | First Water Limited | Treatment of chronic ulcerous skin lesions |
CN101028229B (zh) | 2006-03-02 | 2012-09-05 | 北京富丽华德生物医药科技有限公司 | 基于一氧化氮的新型化妆品 |
CN101062050A (zh) | 2006-04-29 | 2007-10-31 | 北京尼奥克斯生物科技有限公司 | 一种基于一氧化氮的新型生发产品及其制备方法 |
EP2040542A2 (en) | 2006-05-30 | 2009-04-01 | The Dial Corporation | Compositions having a high antiviral effeicacy |
WO2008110872A2 (en) | 2006-06-23 | 2008-09-18 | Foamix Ltd. | Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses |
GB0700911D0 (en) | 2007-01-17 | 2007-02-28 | First Water Ltd | Treatment of inflammation and the complement and kinin cascades in a patient, particularly in chronic ulcerous skin lesions |
GB0700908D0 (en) | 2007-01-17 | 2007-02-28 | First Water Ltd | Inhibition of proteases, particularly in the treatment of chronic ulcerous skin lesions |
GB0715556D0 (en) | 2007-08-09 | 2007-09-19 | Insense Ltd | Improvements relating to skin dressings |
US9278157B2 (en) * | 2007-08-09 | 2016-03-08 | Insense Limited | Nitric oxide-generating skin dressings |
WO2009086470A2 (en) * | 2007-12-27 | 2009-07-09 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
CA2671029A1 (en) * | 2009-06-30 | 2010-12-30 | James S. Baldassarre | Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension |
US20130089629A1 (en) * | 2010-06-07 | 2013-04-11 | Topical Pharma Ab | Kit for the treatment of onychomycosis by nitric oxide |
US20130200109A1 (en) | 2012-02-06 | 2013-08-08 | Frank Yang | Foaming soap dispensers and methods |
CN103690490B (zh) | 2012-08-23 | 2017-11-17 | 尼奥克斯(文莱)控股有限公司 | 基于微囊化化学试剂延时产生一氧化氮的系统和方法 |
US10517817B2 (en) * | 2013-05-09 | 2019-12-31 | Syk Technologies, Llc | Deep topical systemic nitric oxide therapy apparatus and method |
GB201309091D0 (en) | 2013-05-20 | 2013-07-03 | Edixomed Ltd | Dressing system |
GB201309092D0 (en) | 2013-05-20 | 2013-07-03 | Edixomed Ltd | Transdermal delivery system |
CA2946828A1 (en) | 2014-03-14 | 2015-09-17 | Nitric Solutions, Inc. | Treating diseases using nitric oxide releasing solutions |
US10052348B2 (en) | 2016-01-27 | 2018-08-21 | Syk Technologies, Llc | Nitric oxide topical application apparatus and methods |
-
2020
- 2020-06-02 AU AU2020286677A patent/AU2020286677A1/en active Pending
- 2020-06-02 WO PCT/GB2020/051328 patent/WO2020245573A1/en active Search and Examination
- 2020-06-02 GB GB2118473.4A patent/GB2599576B/en active Active
- 2020-06-02 CN CN202080055856.2A patent/CN114206325A/zh active Pending
- 2020-06-02 CA CA3142101A patent/CA3142101A1/en active Pending
- 2020-06-02 EP EP20732271.0A patent/EP3980373A1/en active Pending
- 2020-06-02 US US17/616,468 patent/US20220370493A1/en active Pending
- 2020-06-02 BR BR112021023832A patent/BR112021023832A8/pt unknown
- 2020-06-02 JP JP2021572282A patent/JP2023510661A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN114206325A (zh) | 2022-03-18 |
WO2020245573A1 (en) | 2020-12-10 |
AU2020286677A1 (en) | 2021-12-09 |
CA3142101A1 (en) | 2020-12-10 |
JP2023510661A (ja) | 2023-03-15 |
EP3980373A1 (en) | 2022-04-13 |
GB2599576A (en) | 2022-04-06 |
US20220370493A1 (en) | 2022-11-24 |
BR112021023832A2 (pt) | 2022-01-04 |
GB2599576B (en) | 2023-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112021023832A8 (pt) | Métodos e composições para geração de óxido nítrico e usos dos mesmos | |
BR112021023632A2 (pt) | Métodos e composições para gerar óxido nítrico e usos do mesmo para entregar óxido nítrico através do trato respiratório | |
BR112018067442A8 (pt) | Composto, composição farmacêutica, método de inibir a atividade da amina oxidase, método de tratar uma condição e uso de um composto | |
CL2017001488A1 (es) | Benzamidas sustituidas con 1,3–tiazol–2–ilo | |
BR112014020021A8 (pt) | Composição, método para melhorar a atividade antimicrobiana de um biocida, e, usos de uma poliamina e de uma composição | |
NZ759766A (en) | Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety | |
BR112021025676A2 (pt) | Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella | |
CL2007003666A1 (es) | Compuestos derivados del acido nicotinico; composicion farmaceutica que comprende a dichos compuestos; combinacion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de artritis, esclerosis multiple, psoriasis, entre otras. | |
BR112014011896A2 (pt) | agentes de rnai, composições e métodos de uso destes para o tratamento de doenças associadas à transtirretina (ttr) | |
BR112018010381A2 (pt) | composições para tratamento de cabelo, condicionadora de cabelo e para alteração da cor do cabelo, sistema para tratamento de cabelo, métodos para tratamento de cabelo e para alteração da cor do cabelo, e, kit de multicompartimentos. | |
BR112014012689A8 (pt) | montagem e método de uso de um cateter e método para administração de uma composição antimicrobiana | |
BR112017015773A2 (pt) | muteína de lipocalina, muteína de hngal, molécula de ácido nucleico, célula hospedeira, método para produzir a muteína de hngal, composição farmacêutica, kit, uso da muteína de hngal, uso da muteína de hngal, método para ligar ang-2 em um indivíduo, método para inibir angiogênese em um indivíduo, método para tratar, prevenir ou melhorar uma doença e método para inibir ou reduzir angiogênese em um indivíduo | |
BR112017009028A2 (pt) | métodos e sistema para suprimir corrosão em superfícies de metal. | |
BRPI0903359B8 (pt) | composição farmacêutica de metformina, ácido acetilsalicílico e composto de serotonina para o tratamento do câncer | |
BR112022001341A2 (pt) | Inibidores de enzima | |
BR112019007543A2 (pt) | inibidores de ácido alfa-amino-beta-carboximuconico semialdeido decarboxilase | |
BR112018009837A8 (pt) | composição catalítica e composição curável | |
BR112022008544A2 (pt) | Composições e métodos e usos relacionados às mesmas | |
CL2019001746A1 (es) | Amidas aromáticas de ácido carboxílico | |
CO2022000270A2 (es) | Inhibidores de enzimas | |
BR112022021454A2 (pt) | Óxido nítrico ou composições liberadoras de óxido nítrico para uso no tratamento de sars-cov e sars-cov-2 | |
BR112017018172B8 (pt) | Método para romper um biofilme através de composições compreendendo combinações de ácidos orgânicos | |
BR112022023013A2 (pt) | Inibidores de mek para tratamento ou prevenção de infecções por coronavírus e/ou de tempestade de citocinas de covid-19 | |
WO2020247701A3 (en) | Inhibitors of sarm1 | |
AR101811A1 (es) | Anticuerpo monoclonal humanizado que inhibe la actividad enzimática de la lipasa endotelial vascular |